Considering the increased use of IVIG in IIM, particularly in refractory DM and early in the disease course of IMNM [20, 41–43], these data can still be valuable for understanding IFN-mediated disease mechanisms and their relation to clinical parameters. This evidence concerns the gene IFNA1 and dermatomyositis.